Crossmark

Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of ESR1 mutation

Crossref DOI link: https://doi.org/10.1038/s41523-026-00939-8

Published Online: 2026-04-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Truong, Thu H. https://orcid.org/0000-0003-2394-551X
Gillis, Noelle E.

Dwyer, Amy R.

Huggins, Rosemary J.

Hagen, Kyla M.

Posani, Sai Harshita

Temiz, Nuri A.

Perez Kerkvliet, Carlos

Piepgras, Ellie M.

Ostrander, Julie H.

Greene, Geoffrey L.

Lange, Carol A. https://orcid.org/0000-0003-2751-3976
Funding

Funding for this research was provided by:

National Institutes of Health (K22 CA248615)

National Institutes of Health (K00 CA245796)

National Institutes of Health (R01 CA236948)

National Institutes of Health (R01 CA229697)

METAvivor (Early Investigator Award)

METAvivor (Founder's Award)

University of Minnesota (Tickle Family Land Grant Endowed Chair in Breast Cancer Research)
License Information

Text and Data Mining valid from 2026-04-07

Accepted Manuscript valid from 2026-04-07
More Information

Article History

Received: 8 December 2025

Accepted: 20 March 2026

First Online: 7 April 2026

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below